Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 1
1982 1
1983 2
1984 1
1985 2
1986 3
1987 3
1988 4
1989 2
1990 1
1991 3
1992 1
1993 2
1994 4
1996 1
1999 1
2000 4
2004 4
2005 3
2006 7
2007 14
2008 6
2009 9
2010 16
2011 16
2012 17
2013 13
2014 25
2015 19
2016 26
2017 23
2018 33
2019 27
2020 18
2021 22
2022 25
2023 20
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

340 results

Results by year

Filters applied: . Clear all
Page 1
HAART in HIV/AIDS Treatments: Future Trends.
Lu DY, Wu HY, Yarla NS, Xu B, Ding J, Lu TR. Lu DY, et al. Infect Disord Drug Targets. 2018;18(1):15-22. doi: 10.2174/1871526517666170505122800. Infect Disord Drug Targets. 2018. PMID: 28474549 Review.
An African-Specific Variant of TP53 Reveals PADI4 as a Regulator of p53-Mediated Tumor Suppression.
Indeglia A, Leung JC, Miller SA, Leu JI, Dougherty JF, Clarke NL, Kirven NA, Shao C, Ke L, Lovell S, Barnoud T, Lu DY, Lin C, Kannan T, Battaile KP, Yang THL, Batista Oliva I, Claiborne DT, Vogel P, Liu L, Liu Q, Nefedova Y, Cassel J, Auslander N, Kossenkov AV, Karanicolas J, Murphy ME. Indeglia A, et al. Among authors: lu dy. Cancer Discov. 2023 Jul 7;13(7):1696-1719. doi: 10.1158/2159-8290.CD-22-1315. Cancer Discov. 2023. PMID: 37140445 Free PMC article.
The ETS transcription factor ETV6 constrains the transcriptional activity of EWS-FLI to promote Ewing sarcoma.
Lu DY, Ellegast JM, Ross KN, Malone CF, Lin S, Mabe NW, Dharia NV, Meyer A, Conway A, Su AH, Selich-Anderson J, Taslim C, Byrum AK, Seong BKA, Adane B, Gray NS, Rivera MN, Lessnick SL, Stegmaier K. Lu DY, et al. Nat Cell Biol. 2023 Feb;25(2):285-297. doi: 10.1038/s41556-022-01059-8. Epub 2023 Jan 19. Nat Cell Biol. 2023. PMID: 36658220 Free PMC article.
Ebola Therapeutic Study and Future Directions.
Lu DY, Wu HY, Yarla NS, Lu TR, Xu B, Jian-Ding. Lu DY, et al. Infect Disord Drug Targets. 2019;19(1):17-29. doi: 10.2174/1871526518666180813160348. Infect Disord Drug Targets. 2019. PMID: 30101721 Review.
Drug Combination in Clinical Cancer Treatments.
Lu DY, Lu TR, Yarla NS, Wu HY, Xu B, Ding J, Zhu H. Lu DY, et al. Rev Recent Clin Trials. 2017;12(3):202-211. doi: 10.2174/1574887112666170803145955. Rev Recent Clin Trials. 2017. PMID: 28782482 Review.
Covid-19 Study, Diagnostic and Therapeutic Transition.
Lu DY, Lu TR. Lu DY, et al. Recent Adv Antiinfect Drug Discov. 2023 Mar 31. doi: 10.2174/2772434418666230331115936. Online ahead of print. Recent Adv Antiinfect Drug Discov. 2023. PMID: 36999700
Anthocyanins: Multi-Target Agents for Prevention and Therapy of Chronic Diseases.
Putta S, Yarla NS, Peluso I, Tiwari DK, Reddy GV, Giri PV, Kumar N, Malla R, Rachel V, Bramhachari PV, Reddy D RS, Bade R, Mannarapu M, Barreto GE, Lu DY, Tarasov VV, Chubarev VN, Ribeiro FF, Scotti L, Scotti MT, Kamal MA, Ashraf GM, Aliev G, Perry G, Sarker SD, Rao CV, Bishayee A. Putta S, et al. Among authors: lu dy. Curr Pharm Des. 2017;23(41):6321-6346. doi: 10.2174/1381612823666170519151801. Curr Pharm Des. 2017. PMID: 28741457 Review.
340 results